These are the stocks posting the largest moves in midday trading.
Eli Lilly — The drug maker's stock surged 8% after the firm reported second-quarter earnings and revenue that blew past expectations. Eli Lilly also hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Under Armour — Shares popped 19% after the athletic apparel maker topped quarterly estimates and adjusted its full-year profit guidance. Warner Bros. Discovery — Shares of Warner Bros.
Zillow — Zillow shares rallied more than 18% after the real estate platform reported second-quarter earnings that blew past analyst estimates. The company posted adjusted earnings of 39 cents per share and $572 million in revenue. Duolingo — The language learnings platform's stock jumped 7% on better-than-expected quarterly figures. The move put shares on pace for their biggest one-day gain since February.
Robinhood Markets Inc PENN Entertainment Inc Breaking News Market Insider Markets Economy Stock Markets Breaking News: Markets Business Eli Lilly And Co Under Armour Inc Warner Bros Discovery Inc Occidental Petroleum Corp Klaviyo Inc Dutch Bros Inc Parker-Hannifin Corp Zillow Group Inc Duolingo Inc Bumble Inc Solaredge Technologies Inc Celsius Holdings Inc Jfrog Ltd Sonos Inc Monster Beverage Corp Hanesbrands Inc Earnings Dividends Business News
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stocks making the biggest moves premarket: Eli Lilly, Under Armour, Warner Bros. Discovery and moreThese are the stocks posting the largest moves in premarket trading.
Read more »
Novo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Wednesday's analyst calls: Eli Lilly gets a price target increase, Goldman sees Tesla declineTesla and a pharmaceutical giant were among the stocks analysts were talking about on Wednesday.
Read more »
Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales SoarRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarterli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker.
Read more »
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarterli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker.
Read more »